SlideShare a Scribd company logo
1 of 43
Download to read offline
Bleeding Diathesis
Thamir .D Alotaify
1100020
Bleeding disorders
• Def / a group of hematological diseases
interfer with normal hemostasis
• Types :
- Hypocoagulability
- hypercoagulability
( bleeding tendency) ( thrombosis tendency )
Normal hemostasis
In case of hemorrhage , there will be normal
responce to stop the bleeding
1- vasocostriction :
Due to :
A- direct myogenic spasm
B- platelet ( throboxane A2)
C- neuronal
2- platelet pulg
• Mechanism :
When there is an endothelial injury
Platelet aggregation will takes place
When the platelets attatched to each other they
will be activated and platelet pulg will occures
3- coagulation cascade
• 1- coagulation factors
• 2- prothrombin
• 3- Ca+
1-Vasopathies
• I. Congenital
• • Telangiectasiae (Rendu-Osler-Weber disease)
• Aneurysm of fine vessels
• Ehlers-Danlos syndrome, Marfan’s syndrome,
retinocerebral angiomatosis (von Hippel-Lindau
syndrome), encephalotrigeminal angiomatosis (SturgeKalisher-Weber syndrome)
• II. Acquired
• • Hemorrhagic vasculitis – Henoch-Schönlein purpura
• Immune vasculitis
• Systemic vasculitis
• Avitaminosis of vitamin C
2- platelet abnormalities :
• Hypocoagulability :
2- platelet abnormalities :
Decrease platelet count → increases bleeding time
a) Viral infections
b) Bone marrow failure
c) ITP
d)TTP
e) Drugs
f) Antiphospholipid syndrome
3- Coagulation factors abnormalities
1- anticoagulant drugs
2- decrease production ( hepatic failure )
3- nephrotic syndrome
4- sepsis
5- vitK defeciency
6- genetic ( hemophilia )
•I. Congenital
• Deficiency of coagulation factor VIII (hemophilia A)
• Deficiency of coagulation factor IX (hemophilia B)
• Deficiency of coagulation factor XI (hemophilia C)
• Deficiency of other coagulation factors (I, II, V, VII,
IX, X and XIII)
• Deficiency of XII factor, prekallikrein or kininogen,
protein C and S (without excessive bleeding)
• von Willebrand’s disease (angiohemophilia)
Bleeding diathesis dr . Thamir alotaify
Terminology
Purpura is the appearance of red or purple discolorations on
the skin that do not blanch on applying pressure(3–10 mm).
A petechia is a small (1 - 2 mm) red or purple spot on the body.
An ecchymosis is subcutaneous purpura larger than 1
centimeter .
Hemarthrosis is a bleeding into joint spaces.
A hematoma is a localized collection of blood outside the blood
vessels.
Clinical Features of Bleeding Disorders
Platelet
disorders

Coagulation
factor disorders

Site of bleeding tissues

Skin
Mucous membranes
(epistaxis, gum,
vaginal, GI tract)

Deep in soft
(joints, muscles)

Petechiae

Yes

No

Ecchymoses (“bruises”)

Small, superficial

Large, deep

Hemarthrosis / muscle bleeding

Extremely rare

Common

Bleeding after cuts & scratches

Yes

No

Bleeding after surgery or trauma

Immediate,
usually mild

Delayed (1-2 days),

often severe
Platelet

Petechiae, Purpura

Coagulation

Hematoma, Joint bl.
Petechiae

(typical of platelet disorders)
Hemarthrosis
Hematoma
Petechiae
Purpura
Ecchymosis
Senile Purpura

 Solar purpura or Senile purpura is a skin condition characterized by large, sharply outlined, 1to 5-cm, dark purplish-red ecchymoses appearing on the dorsa of the forearms and less often
the hands.The condition is most common in elderly white persons. It is caused by sun-induced
damage to the connective tissue of the skin.
Petechiae in patient
with Rocky Mountain
Spotted Fever

Rocky Mountain spotted fever (RMSF) is a tick-borne disease caused by the
organism Rickettsia rickettsii.
Henoch-Schonlein purpura

 Henoch-Schoenlein purpura is an acute immunoglobulin A (IgA)–mediated
leukocytoclastic vasculitis that primarily affects children.
Ecchymoses
(typical of coagulation factor disorders)
Coagulation profile
Amir Mohammed
Coagulation Profile
OVERVIEW
•Prothrombin Time
•Activated Partial Thromboplastin Time
•Thrombin Time
•Fibrinogen
•Fibrin Degradation Products (FDP’s)
•APTT 50% NP
•Retiplase Time
•Euglobin Lysis Time
•Urea solubility Test
PROTHROMBIN TIME
• This measures the clotting time of plasma after the
addition of brain extract containing tissue
thromboplastin.
• This will test the extrinsic clotting pathway involving
factors V, VII, X and Fibrinogen.
• The reference range for prothrombin time depends
on the analytical method used, but is usually around
12-13 seconds
• Prolongation of the Prothrombin Time is seen in,

1)
2)
3)
4)

Liver cell dysfunction
Vitamin K deficiency
Warfarin therapy
Disseminated Intravascular Coagulation (DIC)
ACTIVATED PARTIAL THROMBOPLASTIN TIME
• This will test for defects in the extrinsic pathway.
• The clotting factors are Factors, XII, XI, IX, VIII, X, V, II
and I
• The typical reference range is between
30 seconds and 50 s
• Prolongation of APTT is seen in,






Haemophilia A and B (Factors VIII and IX)
Von Willebrandt's Disease (stabilizing factor for factor VII
Other factor deficiencies (XII, XI)
Liver failure
Disseminated Intravscular Coagulation.

ed)
THROMBIN TIME
• thrombin added to undiluted plasma
• tests the conversion of fibrinogen -> fibrin
• The reference ranges of the Thrombin Clotting
time is generally <22 seconds,
• prolonged in:
-> heparin
-> DIC
-> hypofibrinogenaemia
-> fibrin degradation products
FIBRINOGEN
• normal: 1.5-4.0
• high in: acute phase response
• low in:
-> sepsis
-> DIC
FIBRIN DEGRADATION PRODUCTS (FDPs)
• marker of fibrin and fibrinogen breakdown
• The reference range of FDP levels is less than 10
mcg/mL (conventional units) or less than 10 mg/L
(SI units).
APTT 50% NP
• mixing of patients sample with pooled normal plasma – 50:50
mix
• failure to correct after mixing:
• -> lupus anticoagulant

ECHIS TIME
•
•
•
•
•
•

snake venom from Echis multisquamatus added to sample
differentiates liver dysfunction from vitamin deficiency
this activates prothrombin without requiring vitamin K
is normal in vitamin K deficiency or warfarin use
The reference ranges is 10.5 - 15 sec
if prolonged:
-> factor deficiency (liver disease)
RETIPLASE TIME
• used to detect deficiency or abnormalities in
fibrinogen
• snake venom that has similar action to thrombin but
is resistant to inhibition by antithrombin III
• interpret with TCT
• if retiplase time normal and TCT prolonged:
-> heparin
-> hirudin
-> direct thrombin inhibitors
EUGLOBIN LYSIS TIME
• shortened time:
• -> presence of systemic fibrinolytic pathway
activators
UREA SOLUBILITY TEST
• factor 13 stabilises fibrin
• if deficient 5M urea will dissolve it
Treatment
By:fahad saad alenzi
1100026
• Children:
• Children do not usually require treatment, Where
this is necessary on clinical grounds.
• high-dose prednisolone is effective, given for a very
short course.
• Intravenous immunoglobulin (i.v. IgG) should be
reserved for very serious bleeding or urgent surgery.
• Chronic ITP is rare and requires specialist
management.
• Adults:
• Patients with platelet counts greater than
30 × 10^9/L require no urgent treatment
unless they are about to undergo a
surgical procedure.
• First-line therapy :
• consists of oral corticosteroids 1 mg/kg body weight.
• Approximately 66% will respond to prednisolone but relapse
is common when the dose is reduced.
• Only 33% of patients can expect a long-term response and
long term remission is seen in only 10–20% of patients
following stopping prednisolone.
• Patients who fail to respond to corticosteroids or require high
doses to maintain a safe platelet count should be considered
for splenectomy.
• Intravenous immunoglobulin (i.v. IgG) is effective, It
raises platelet count in 75% and in 50% the platelet
count will normalize , Responses are only transient
(3–4 weeks) with little evidence of any lasting effect.
• However, it is very useful where a rapid rise in
platelet count is desired, especially before surgery.
• There are also advocates for high dose
corticosteroids for additional therapy.
• Second-line therapy: involves splenectomy, to
which the majority of patients respond – twothirds will achieve a normal platelet count.
• Patients who do not have a complete
response can still expect some improvement.
• Third-line therapy; For those that fail splenectomy,
•
•






a wide range of other therapies are available,
These include;
highdose corticosteroids,
intravenous immunoglobulin,
vinca alkaloids, danazol,
Immunosuppressive agents such as ciclosporin and dapsone.
combination chemotherapy, mycophenolate mofetil.
• Major difficulties with many third-line
therapies are modest response rates and slow
onset of action, Consequently ,there is also
interest in the use of specific monoclonal
antibodies such as rituximab, as well as
recombinant thrombopoietin.
• However, clinical trials of thrombopoietin were
stopped because of thrombocytopenia but
eltrombopag a thrombopoietin receptor agonist
(which binds to another point of the thrombopoietin
receptor), has been shown to increase platelets in
ITP.
• Romiplostim ; a novel thrombopoiesis protein given
weekly subcutaneously, has also been shown to
significantly increase platelet count in ITP on a longterm basis, there were no major adverse effects in
this trial.
• Platelet transfusions are reserved for intracranial or
other extreme haemorrhage, where emergency
splenectomy may be justified.
Bleeding diathesis dr . Thamir alotaify

More Related Content

What's hot

What's hot (20)

Reactive Arthritis
Reactive  ArthritisReactive  Arthritis
Reactive Arthritis
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Polymyositis
PolymyositisPolymyositis
Polymyositis
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Thrombosis
ThrombosisThrombosis
Thrombosis
 
Thrombosis
ThrombosisThrombosis
Thrombosis
 
Haemophilic arthritis
Haemophilic arthritisHaemophilic arthritis
Haemophilic arthritis
 
Fracture healing
Fracture  healingFracture  healing
Fracture healing
 
Hand deformity in rheumatoid arthritis
Hand deformity in rheumatoid arthritisHand deformity in rheumatoid arthritis
Hand deformity in rheumatoid arthritis
 
Muscle stiffness and spasm
Muscle stiffness and spasmMuscle stiffness and spasm
Muscle stiffness and spasm
 
Buerger's disease ( Thromboangiitis obliterans)
Buerger's  disease  ( Thromboangiitis obliterans)Buerger's  disease  ( Thromboangiitis obliterans)
Buerger's disease ( Thromboangiitis obliterans)
 
Osgood Schlatter Disease
Osgood Schlatter DiseaseOsgood Schlatter Disease
Osgood Schlatter Disease
 
Osteomyelitis
OsteomyelitisOsteomyelitis
Osteomyelitis
 
Thrombosis, embolism and infarction
Thrombosis, embolism and infarctionThrombosis, embolism and infarction
Thrombosis, embolism and infarction
 
Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
 
Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
 
Tuberculosis of the spine
Tuberculosis of the spineTuberculosis of the spine
Tuberculosis of the spine
 
Rheumatic Heart Disease
 Rheumatic Heart Disease Rheumatic Heart Disease
Rheumatic Heart Disease
 
Osteoarthritis knee
Osteoarthritis  kneeOsteoarthritis  knee
Osteoarthritis knee
 
Osteomyelitis
Osteomyelitis Osteomyelitis
Osteomyelitis
 

Viewers also liked

Bleeding diathesis
Bleeding diathesisBleeding diathesis
Bleeding diathesisMoin Mir
 
Approach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in childrenApproach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in childrenSatish Vadapalli
 
5. bleeding disorder
5. bleeding disorder5. bleeding disorder
5. bleeding disorderWhiteraven68
 
Approach to diagnosis of bleeding disorders
Approach to diagnosis of bleeding disordersApproach to diagnosis of bleeding disorders
Approach to diagnosis of bleeding disordersBiswajeeta Saha
 
Surgery in Bleeding disorders- A challenging problem to all surgeons
Surgery in Bleeding disorders- A challenging problem to all surgeonsSurgery in Bleeding disorders- A challenging problem to all surgeons
Surgery in Bleeding disorders- A challenging problem to all surgeonsSelvaraj Balasubramani
 
Presantation on bleeding disorder in pediatric patients
Presantation on bleeding disorder in pediatric patientsPresantation on bleeding disorder in pediatric patients
Presantation on bleeding disorder in pediatric patientsSiraj Shiferaw
 
Bleeding 100308055003 Phpapp02
Bleeding 100308055003 Phpapp02Bleeding 100308055003 Phpapp02
Bleeding 100308055003 Phpapp02MD Specialclass
 
Leukemia in children
Leukemia in childrenLeukemia in children
Leukemia in childrenkellseyf
 
How to approach a child with bleeding disorder
How to approach a child with bleeding disorderHow to approach a child with bleeding disorder
How to approach a child with bleeding disorderKamran Akbar
 
Leukemias in children
Leukemias in childrenLeukemias in children
Leukemias in childrengiridharkv
 
Anemia in children 2014
Anemia in children 2014Anemia in children 2014
Anemia in children 2014SHO-medicine
 
Anaemia in children
Anaemia in childrenAnaemia in children
Anaemia in childrengiridharkv
 

Viewers also liked (20)

Bleeding diathesis
Bleeding diathesisBleeding diathesis
Bleeding diathesis
 
Approach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in childrenApproach to bleeding disorder (coagulation defects) in children
Approach to bleeding disorder (coagulation defects) in children
 
5. bleeding disorder
5. bleeding disorder5. bleeding disorder
5. bleeding disorder
 
Approach to diagnosis of bleeding disorders
Approach to diagnosis of bleeding disordersApproach to diagnosis of bleeding disorders
Approach to diagnosis of bleeding disorders
 
Surgery in Bleeding disorders- A challenging problem to all surgeons
Surgery in Bleeding disorders- A challenging problem to all surgeonsSurgery in Bleeding disorders- A challenging problem to all surgeons
Surgery in Bleeding disorders- A challenging problem to all surgeons
 
Surgery in Bleeding Diathesis
Surgery in Bleeding DiathesisSurgery in Bleeding Diathesis
Surgery in Bleeding Diathesis
 
Bleeding disorder
Bleeding disorderBleeding disorder
Bleeding disorder
 
Approach to bleeding disorder
Approach to bleeding disorderApproach to bleeding disorder
Approach to bleeding disorder
 
CME: Bleeding disorders - Diagnostic Approach
CME: Bleeding disorders - Diagnostic ApproachCME: Bleeding disorders - Diagnostic Approach
CME: Bleeding disorders - Diagnostic Approach
 
Presantation on bleeding disorder in pediatric patients
Presantation on bleeding disorder in pediatric patientsPresantation on bleeding disorder in pediatric patients
Presantation on bleeding disorder in pediatric patients
 
Bleeding 100308055003 Phpapp02
Bleeding 100308055003 Phpapp02Bleeding 100308055003 Phpapp02
Bleeding 100308055003 Phpapp02
 
Sindrome hemorragico
Sindrome hemorragico Sindrome hemorragico
Sindrome hemorragico
 
Leukemia in children
Leukemia in childrenLeukemia in children
Leukemia in children
 
CME: Bleeding Disorders - Management
CME: Bleeding Disorders - ManagementCME: Bleeding Disorders - Management
CME: Bleeding Disorders - Management
 
How to approach a child with bleeding disorder
How to approach a child with bleeding disorderHow to approach a child with bleeding disorder
How to approach a child with bleeding disorder
 
UTI in children
UTI in childrenUTI in children
UTI in children
 
Leukemias in children
Leukemias in childrenLeukemias in children
Leukemias in children
 
Anemia in children 2014
Anemia in children 2014Anemia in children 2014
Anemia in children 2014
 
Anaemias
AnaemiasAnaemias
Anaemias
 
Anaemia in children
Anaemia in childrenAnaemia in children
Anaemia in children
 

Similar to Bleeding diathesis dr . Thamir alotaify

Bleeding and coagulopathy
Bleeding and coagulopathyBleeding and coagulopathy
Bleeding and coagulopathybuntyrocks
 
Thrombocytopenia and ITP
Thrombocytopenia and ITPThrombocytopenia and ITP
Thrombocytopenia and ITPSOLOMON SUASB
 
Bleeding Disorders: Classification and Diagnosis
Bleeding Disorders: Classification and DiagnosisBleeding Disorders: Classification and Diagnosis
Bleeding Disorders: Classification and DiagnosisRajat Hegde
 
OVERVIEW Disorders of platelets
OVERVIEW Disorders of plateletsOVERVIEW Disorders of platelets
OVERVIEW Disorders of plateletsVidur Singh
 
Disseminated intravascular-coagulation (2)
Disseminated intravascular-coagulation (2)Disseminated intravascular-coagulation (2)
Disseminated intravascular-coagulation (2)Kazi Oly
 
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptxbleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptxMohanSinghDhakad1
 
Bleeding disorders in children.ppt
Bleeding disorders in children.pptBleeding disorders in children.ppt
Bleeding disorders in children.pptagbenorxevidennis
 
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptxbleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptxMohanSinghDhakad1
 
Disseminated Intravascular Coagulopathy.pdf
Disseminated Intravascular Coagulopathy.pdfDisseminated Intravascular Coagulopathy.pdf
Disseminated Intravascular Coagulopathy.pdfabimbolaoyebolaji
 
Disordersof hemostasis(Dr MURALI BM)
Disordersof hemostasis(Dr MURALI BM)Disordersof hemostasis(Dr MURALI BM)
Disordersof hemostasis(Dr MURALI BM)MINDS MAHE
 
clinical approach to patients with bleeding tendency
clinical approach to patients with bleeding tendencyclinical approach to patients with bleeding tendency
clinical approach to patients with bleeding tendencyReem Alyahya
 
Hemostasis Disorders
Hemostasis DisordersHemostasis Disorders
Hemostasis DisordersCSN Vittal
 
Approach to a child with bleeding for UGs
Approach to a child with bleeding for UGsApproach to a child with bleeding for UGs
Approach to a child with bleeding for UGsCSN Vittal
 
Thrombocytopenia lecture for v yr mbbs
Thrombocytopenia lecture for v yr mbbsThrombocytopenia lecture for v yr mbbs
Thrombocytopenia lecture for v yr mbbsmona aziz
 
Thrombocytopenia during pregnancy
Thrombocytopenia during pregnancyThrombocytopenia during pregnancy
Thrombocytopenia during pregnancymuhammad al hennawy
 

Similar to Bleeding diathesis dr . Thamir alotaify (20)

Bleeding and coagulopathy
Bleeding and coagulopathyBleeding and coagulopathy
Bleeding and coagulopathy
 
Thrombocytopenia and ITP
Thrombocytopenia and ITPThrombocytopenia and ITP
Thrombocytopenia and ITP
 
Bleeding Disorders: Classification and Diagnosis
Bleeding Disorders: Classification and DiagnosisBleeding Disorders: Classification and Diagnosis
Bleeding Disorders: Classification and Diagnosis
 
Hemostasis disorders
Hemostasis disordersHemostasis disorders
Hemostasis disorders
 
Hemostasis
HemostasisHemostasis
Hemostasis
 
OVERVIEW Disorders of platelets
OVERVIEW Disorders of plateletsOVERVIEW Disorders of platelets
OVERVIEW Disorders of platelets
 
Disseminated intravascular-coagulation (2)
Disseminated intravascular-coagulation (2)Disseminated intravascular-coagulation (2)
Disseminated intravascular-coagulation (2)
 
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptxbleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
 
Bleeding disorders in children.ppt
Bleeding disorders in children.pptBleeding disorders in children.ppt
Bleeding disorders in children.ppt
 
Coagulopathy
CoagulopathyCoagulopathy
Coagulopathy
 
Platelets .pptx
Platelets .pptxPlatelets .pptx
Platelets .pptx
 
Hemostasis disorder
Hemostasis disorderHemostasis disorder
Hemostasis disorder
 
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptxbleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
bleeding-timeclotting-time-pt-and-ptt-130504122408-phpapp01.pptx
 
Disseminated Intravascular Coagulopathy.pdf
Disseminated Intravascular Coagulopathy.pdfDisseminated Intravascular Coagulopathy.pdf
Disseminated Intravascular Coagulopathy.pdf
 
Disordersof hemostasis(Dr MURALI BM)
Disordersof hemostasis(Dr MURALI BM)Disordersof hemostasis(Dr MURALI BM)
Disordersof hemostasis(Dr MURALI BM)
 
clinical approach to patients with bleeding tendency
clinical approach to patients with bleeding tendencyclinical approach to patients with bleeding tendency
clinical approach to patients with bleeding tendency
 
Hemostasis Disorders
Hemostasis DisordersHemostasis Disorders
Hemostasis Disorders
 
Approach to a child with bleeding for UGs
Approach to a child with bleeding for UGsApproach to a child with bleeding for UGs
Approach to a child with bleeding for UGs
 
Thrombocytopenia lecture for v yr mbbs
Thrombocytopenia lecture for v yr mbbsThrombocytopenia lecture for v yr mbbs
Thrombocytopenia lecture for v yr mbbs
 
Thrombocytopenia during pregnancy
Thrombocytopenia during pregnancyThrombocytopenia during pregnancy
Thrombocytopenia during pregnancy
 

Recently uploaded

AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxNaveenkumar267201
 

Recently uploaded (20)

AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptxBreast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
Breast cancer -ONCO IN MEDICAL AND SURGICAL NURSING.pptx
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 

Bleeding diathesis dr . Thamir alotaify

  • 1. Bleeding Diathesis Thamir .D Alotaify 1100020
  • 2. Bleeding disorders • Def / a group of hematological diseases interfer with normal hemostasis • Types : - Hypocoagulability - hypercoagulability ( bleeding tendency) ( thrombosis tendency )
  • 3. Normal hemostasis In case of hemorrhage , there will be normal responce to stop the bleeding 1- vasocostriction : Due to : A- direct myogenic spasm B- platelet ( throboxane A2) C- neuronal
  • 4. 2- platelet pulg • Mechanism : When there is an endothelial injury Platelet aggregation will takes place When the platelets attatched to each other they will be activated and platelet pulg will occures
  • 5. 3- coagulation cascade • 1- coagulation factors • 2- prothrombin • 3- Ca+
  • 6. 1-Vasopathies • I. Congenital • • Telangiectasiae (Rendu-Osler-Weber disease) • Aneurysm of fine vessels • Ehlers-Danlos syndrome, Marfan’s syndrome, retinocerebral angiomatosis (von Hippel-Lindau syndrome), encephalotrigeminal angiomatosis (SturgeKalisher-Weber syndrome) • II. Acquired • • Hemorrhagic vasculitis – Henoch-Schönlein purpura • Immune vasculitis • Systemic vasculitis • Avitaminosis of vitamin C
  • 7. 2- platelet abnormalities : • Hypocoagulability : 2- platelet abnormalities : Decrease platelet count → increases bleeding time a) Viral infections b) Bone marrow failure c) ITP d)TTP e) Drugs f) Antiphospholipid syndrome
  • 8. 3- Coagulation factors abnormalities 1- anticoagulant drugs 2- decrease production ( hepatic failure ) 3- nephrotic syndrome 4- sepsis 5- vitK defeciency 6- genetic ( hemophilia )
  • 9. •I. Congenital • Deficiency of coagulation factor VIII (hemophilia A) • Deficiency of coagulation factor IX (hemophilia B) • Deficiency of coagulation factor XI (hemophilia C) • Deficiency of other coagulation factors (I, II, V, VII, IX, X and XIII) • Deficiency of XII factor, prekallikrein or kininogen, protein C and S (without excessive bleeding) • von Willebrand’s disease (angiohemophilia)
  • 11. Terminology Purpura is the appearance of red or purple discolorations on the skin that do not blanch on applying pressure(3–10 mm). A petechia is a small (1 - 2 mm) red or purple spot on the body. An ecchymosis is subcutaneous purpura larger than 1 centimeter . Hemarthrosis is a bleeding into joint spaces. A hematoma is a localized collection of blood outside the blood vessels.
  • 12. Clinical Features of Bleeding Disorders Platelet disorders Coagulation factor disorders Site of bleeding tissues Skin Mucous membranes (epistaxis, gum, vaginal, GI tract) Deep in soft (joints, muscles) Petechiae Yes No Ecchymoses (“bruises”) Small, superficial Large, deep Hemarthrosis / muscle bleeding Extremely rare Common Bleeding after cuts & scratches Yes No Bleeding after surgery or trauma Immediate, usually mild Delayed (1-2 days), often severe
  • 20. Senile Purpura  Solar purpura or Senile purpura is a skin condition characterized by large, sharply outlined, 1to 5-cm, dark purplish-red ecchymoses appearing on the dorsa of the forearms and less often the hands.The condition is most common in elderly white persons. It is caused by sun-induced damage to the connective tissue of the skin.
  • 21. Petechiae in patient with Rocky Mountain Spotted Fever Rocky Mountain spotted fever (RMSF) is a tick-borne disease caused by the organism Rickettsia rickettsii.
  • 22. Henoch-Schonlein purpura  Henoch-Schoenlein purpura is an acute immunoglobulin A (IgA)–mediated leukocytoclastic vasculitis that primarily affects children.
  • 25. Coagulation Profile OVERVIEW •Prothrombin Time •Activated Partial Thromboplastin Time •Thrombin Time •Fibrinogen •Fibrin Degradation Products (FDP’s) •APTT 50% NP •Retiplase Time •Euglobin Lysis Time •Urea solubility Test
  • 26. PROTHROMBIN TIME • This measures the clotting time of plasma after the addition of brain extract containing tissue thromboplastin. • This will test the extrinsic clotting pathway involving factors V, VII, X and Fibrinogen. • The reference range for prothrombin time depends on the analytical method used, but is usually around 12-13 seconds • Prolongation of the Prothrombin Time is seen in, 1) 2) 3) 4) Liver cell dysfunction Vitamin K deficiency Warfarin therapy Disseminated Intravascular Coagulation (DIC)
  • 27. ACTIVATED PARTIAL THROMBOPLASTIN TIME • This will test for defects in the extrinsic pathway. • The clotting factors are Factors, XII, XI, IX, VIII, X, V, II and I • The typical reference range is between 30 seconds and 50 s • Prolongation of APTT is seen in,      Haemophilia A and B (Factors VIII and IX) Von Willebrandt's Disease (stabilizing factor for factor VII Other factor deficiencies (XII, XI) Liver failure Disseminated Intravscular Coagulation. ed)
  • 28. THROMBIN TIME • thrombin added to undiluted plasma • tests the conversion of fibrinogen -> fibrin • The reference ranges of the Thrombin Clotting time is generally <22 seconds, • prolonged in: -> heparin -> DIC -> hypofibrinogenaemia -> fibrin degradation products
  • 29. FIBRINOGEN • normal: 1.5-4.0 • high in: acute phase response • low in: -> sepsis -> DIC FIBRIN DEGRADATION PRODUCTS (FDPs) • marker of fibrin and fibrinogen breakdown • The reference range of FDP levels is less than 10 mcg/mL (conventional units) or less than 10 mg/L (SI units).
  • 30. APTT 50% NP • mixing of patients sample with pooled normal plasma – 50:50 mix • failure to correct after mixing: • -> lupus anticoagulant ECHIS TIME • • • • • • snake venom from Echis multisquamatus added to sample differentiates liver dysfunction from vitamin deficiency this activates prothrombin without requiring vitamin K is normal in vitamin K deficiency or warfarin use The reference ranges is 10.5 - 15 sec if prolonged: -> factor deficiency (liver disease)
  • 31. RETIPLASE TIME • used to detect deficiency or abnormalities in fibrinogen • snake venom that has similar action to thrombin but is resistant to inhibition by antithrombin III • interpret with TCT • if retiplase time normal and TCT prolonged: -> heparin -> hirudin -> direct thrombin inhibitors
  • 32. EUGLOBIN LYSIS TIME • shortened time: • -> presence of systemic fibrinolytic pathway activators UREA SOLUBILITY TEST • factor 13 stabilises fibrin • if deficient 5M urea will dissolve it
  • 34. • Children: • Children do not usually require treatment, Where this is necessary on clinical grounds. • high-dose prednisolone is effective, given for a very short course. • Intravenous immunoglobulin (i.v. IgG) should be reserved for very serious bleeding or urgent surgery. • Chronic ITP is rare and requires specialist management.
  • 35. • Adults: • Patients with platelet counts greater than 30 × 10^9/L require no urgent treatment unless they are about to undergo a surgical procedure.
  • 36. • First-line therapy : • consists of oral corticosteroids 1 mg/kg body weight. • Approximately 66% will respond to prednisolone but relapse is common when the dose is reduced. • Only 33% of patients can expect a long-term response and long term remission is seen in only 10–20% of patients following stopping prednisolone. • Patients who fail to respond to corticosteroids or require high doses to maintain a safe platelet count should be considered for splenectomy.
  • 37. • Intravenous immunoglobulin (i.v. IgG) is effective, It raises platelet count in 75% and in 50% the platelet count will normalize , Responses are only transient (3–4 weeks) with little evidence of any lasting effect. • However, it is very useful where a rapid rise in platelet count is desired, especially before surgery. • There are also advocates for high dose corticosteroids for additional therapy.
  • 38. • Second-line therapy: involves splenectomy, to which the majority of patients respond – twothirds will achieve a normal platelet count. • Patients who do not have a complete response can still expect some improvement.
  • 39. • Third-line therapy; For those that fail splenectomy, • •      a wide range of other therapies are available, These include; highdose corticosteroids, intravenous immunoglobulin, vinca alkaloids, danazol, Immunosuppressive agents such as ciclosporin and dapsone. combination chemotherapy, mycophenolate mofetil.
  • 40. • Major difficulties with many third-line therapies are modest response rates and slow onset of action, Consequently ,there is also interest in the use of specific monoclonal antibodies such as rituximab, as well as recombinant thrombopoietin.
  • 41. • However, clinical trials of thrombopoietin were stopped because of thrombocytopenia but eltrombopag a thrombopoietin receptor agonist (which binds to another point of the thrombopoietin receptor), has been shown to increase platelets in ITP.
  • 42. • Romiplostim ; a novel thrombopoiesis protein given weekly subcutaneously, has also been shown to significantly increase platelet count in ITP on a longterm basis, there were no major adverse effects in this trial. • Platelet transfusions are reserved for intracranial or other extreme haemorrhage, where emergency splenectomy may be justified.